Sykes B W, Underwood C, Mills P C
School of Veterinary Science, The University of Queensland, Gatton, Queensland, Australia.
Bova Compounding, Caringbah, New South Wales, Australia.
Equine Vet J. 2017 Sep;49(5):637-642. doi: 10.1111/evj.12670. Epub 2017 Feb 22.
Esomeprazole warrants further investigation as a treatment for equine gastric ulcer syndrome.
To investigate the duration of intraday acid suppression achieved with two doses of esomeprazole under two dietary conditions.
A four way crossover design.
Six adult Thoroughbreds instrumented with percutaneous gastrotomy tubes were used. Intragastric pH was measured for continuous 23 h periods (08.00-07.00 h) for 6 consecutive days (Days 0-5). Baseline data was recorded on Day 0 and esomeprazole was administered on Days 1-5. Two doses (0.5 and 2.0 mg/kg bwt/day per os once daily) and two diets (a high grain/low fibre (HG/LF) and ad libitum hay (HAY) diet) were studied. Data for the percentage of time pH was above 4 (%tpH>4) and median intraday pH was reported for two measurement points and analysed using generalised estimating equations.
An inconsistent effect of both diet and dose was evident with mean %tpH>4 and mean of the median intraday pHs typically higher at the 2.0 mg/kg bwt dose and in HG/LF diet. A cumulative effect of dosing was present with the magnitude of acid suppression observed on Day 5 consistently higher than that observed on Day 1. The magnitude of acid suppression, at measurement point 1, compared favourably with previous reports on omeprazole and exceeded human therapeutic breakpoints for the 0.5 mg/kg bwt dose in the HG/LF diet and 2.0 mg/kg bwt dose in the HAY diet.
Instrumentation may have modified gastric function and horses were not fasted or exercised.
The findings of the present study suggested that both dose and diet affect the response to esomeprazole in the horse and that a cumulative effect is present over the first 5 days of treatment. Further investigation into the clinical efficacy of esomeprazole and trials directly comparing esomeprazole and omeprazole appear to be warranted.
埃索美拉唑作为马胃溃疡综合征的一种治疗方法值得进一步研究。
研究在两种饮食条件下,两种剂量的埃索美拉唑实现的日内抑酸持续时间。
四向交叉设计。
使用六匹装有经皮胃造瘘管的成年纯种马。连续6天(第0 - 5天),每天23小时(08:00 - 07:00)测量胃内pH值。第0天记录基线数据,第1 - 5天给予埃索美拉唑。研究了两种剂量(0.5和2.0毫克/千克体重/天,口服,每日一次)和两种饮食(高谷物/低纤维(HG/LF)和随意采食干草(HAY)饮食)。报告了两个测量点pH值高于4的时间百分比(%tpH>4)和日内pH中位数的数据,并使用广义估计方程进行分析。
饮食和剂量的影响均不一致,通常在2.0毫克/千克体重剂量和HG/LF饮食中,平均%tpH>4和日内pH中位数的平均值更高。给药存在累积效应,第5天观察到的抑酸程度始终高于第1天。在测量点1,抑酸程度与先前关于奥美拉唑的报告相比具有优势,并且在HG/LF饮食中0.5毫克/千克体重剂量和HAY饮食中2.0毫克/千克体重剂量下超过了人类治疗断点。
仪器可能改变了胃功能,且马匹未禁食或运动。
本研究结果表明,剂量和饮食均会影响马对埃索美拉唑的反应,并且在治疗的前5天存在累积效应。似乎有必要进一步研究埃索美拉唑的临床疗效,并进行直接比较埃索美拉唑和奥美拉唑的试验。